Treatment of essential tremor with arotinolol
- PMID: 2451192
- DOI: 10.1212/wnl.38.4.650
Treatment of essential tremor with arotinolol
Abstract
We investigated the effect of arotinolol, a new peripherally acting beta-adrenergic blocker, in 15 patients with essential tremor. The patients received 30 mg per day of arotinolol for 8 weeks. Accelerometer readings showed a significant reduction in amplitude of postural tremor after treatment. Action tremor also improved to essentially the same degree as postural tremor. The present findings support the view that the therapeutic effect of beta-blockers in essential tremor is mediated by peripheral beta-adrenergic receptors.
Similar articles
-
Treatment of resting tremor by beta-adrenergic blockade.Am Heart J. 1984 Oct;108(4 Pt 2):1173-7. doi: 10.1016/0002-8703(84)90603-3. Am Heart J. 1984. PMID: 6148881 Clinical Trial.
-
Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.Ann Neurol. 1984 Oct;16(4):505-8. doi: 10.1002/ana.410160412. Ann Neurol. 1984. PMID: 6149724 Clinical Trial.
-
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.Clin Neuropharmacol. 1992 Oct;15(5):381-6. doi: 10.1097/00002826-199210000-00005. Clin Neuropharmacol. 1992. PMID: 1384970
-
[Beta blockers in the treatment of neurological disorders].Srp Arh Celok Lek. 1992 Jun;120 Suppl 4:54-8. Srp Arh Celok Lek. 1992. PMID: 18193812 Review. Serbian.
-
An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.Drugs. 1993 Apr;45(4):509-17. doi: 10.2165/00003495-199345040-00003. Drugs. 1993. PMID: 7684671 Review.
Cited by
-
Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.CNS Drugs. 2008;22(12):1037-45. doi: 10.2165/0023210-200822120-00006. CNS Drugs. 2008. PMID: 18998741 Review.
-
Benefits and risks of pharmacological treatments for essential tremor.Drug Saf. 2003;26(7):461-81. doi: 10.2165/00002018-200326070-00003. Drug Saf. 2003. PMID: 12735785 Review.
-
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.Curr Neuropharmacol. 2020;18(6):518-537. doi: 10.2174/1570159X18666200124145743. Curr Neuropharmacol. 2020. PMID: 31976837 Free PMC article. Review.
-
Transducer-based evaluation of tremor.Mov Disord. 2016 Sep;31(9):1327-36. doi: 10.1002/mds.26671. Epub 2016 Jun 6. Mov Disord. 2016. PMID: 27273470 Free PMC article. Review.
-
Essential Tremor.Curr Treat Options Neurol. 1999 Mar;1(1):6-13. doi: 10.1007/s11940-999-0027-3. Curr Treat Options Neurol. 1999. PMID: 11096690
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical